Publication | Open Access
Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
259
Citations
12
References
2019
Year
Fractionated dosing of CTL019 with intrapatient dose modification optimizes safety without compromising efficacy in adults with r/r ALL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1